Industry
Your search returned 19383 results
{0} results
{0} result
People
View 2694 more >Capabilities
View 413 more >News & Awards
View 2662 more >Awards and Rankings
Hogan Lovells wins the Pro Bono Initiative of the Year award at The Lawyer Awards
London, 26 June 2019 - Hogan Lovells is delighted to announce that the firm has won the 'Pro Bono Initiative of the Year' award at The Lawyer Awards in Association with Travelers.
Press Releases
It's not about Brexit anymore: EU Summit serves as important reminder for businesses that political due diligence must be broader than Brexit
London, Brussels, Washington D.C., 25 June 2019 – With Europe's political leaders gathering to discuss the future of the Eurozone in Brussels last week, much of the debate...
Press Releases
Hogan Lovells advises Europcar Mobility Group in relation to the acquisition of its Finnish and Norwegian franchisees
Hogan Lovells advised Europcar Mobility Group, a major player in mobility services, in relation to its acquisition of Europcar Finland and Europcar Norway.
Press Releases
Hogan Lovells advises Covestro on the sale of its European polyurethane system houses
Led by its Dusseldorf partner Jens Uhlendorf, international law firm Hogan Lovells advised Covestro AG on the sale of its European polyurethane system houses in Germany, the Netherlands,...
Publications
View 7036 more >Hogan Lovells Publications
China's tariff exclusion process
On 13 May 2019 China's State Council Tariff Commission announced a tariff exclusion process in which importers of certain U.S. goods subject to retaliatory tariffs can apply for exclusions...
Hogan Lovells Publications
USTR released the Section 301 product exclusion process for List 3 goods from China
On 20 June 2019 the Office of the United States Trade Representative (USTR) announced the final product exclusion process for List 3 by which U.S. stakeholders can request exclusion of...
Hogan Lovells Publications
FIG Bulletin, 21 June 2019
We are delighted to send you our latest e-newsletter, setting out recent developments.
Topic Centers
View 3616 more >Blog Post
PSD2 and SCA – September or beyond?
On 21 June 2019 the EBA published an opinion on the elements of strong customer authentication. As well as setting out some important clarifications on the interpretation of the...
Blog Post
A big step towards the legalisation of therapeutic cannabis in France
The French legislator has always placed strict restrictions on the use of therapeutic cannabis. But the situation and legislation are about to evolve in France.
Blog Post
FDA launches temporary “TRIP” program to help HCT/P sponsors gain regulatory clarity
Acting Food and Drug Administration (FDA) Commissioner Ned Sharpless, M.D. recently announced that FDA is implementing a temporary program called the Tissue Reference Group Rapid...
Blog Post
FDA issues benefit-risk framework for assessing opioid drug applications, announces public meeting
Agency seeks input on “comparative advantage” requirement for new opioids
Events
View 1373 more >Events
A Year of Corporate Governance: AGMs - a Season of Discontent
Whether you’re an established UK listed company or you’ve recently been through an IPO, we’ll guide you through life as a publicly listed company, working with you every...
Sponsorships and Speaking Engagements
Applying FDA's Rules in the New World of Online Marketing and Crowdsourcing
The 2019 Regulatory Affairs Professionals Society (RAPS) Regulatory Convergence will take place in Philadelphia.
Sponsorships and Speaking Engagements
Introduction to Drug, Biologics, and Biosimilars Law and Regulation
Scott Kaplan will be presenting the segment titled "Regulation of Manufacturing" at the Food and Drug Law Institute's Introduction to Drug, Biologics, and Biosimilars Law and Regulation...
Webinar
D&O liability risks arising from antitrust law violations
Our German Corporate Litigation team regularly hosts webinars on different corporate litigation topics.
Others
View 1561 more >A Year of Corporate Governance: Keeping Markets Updated
Whether you’re an established UK listed company or you’ve recently been through an IPO, we’ll guide you through life as a publicly listed company, working with you every...
A Year of Corporate Governance: Remuneration
Whether you’re an established UK listed company or you’ve recently been through an IPO, we’ll guide you through life as a publicly listed company, working with you every...
Collective Actions for Damages recent developments in the Netherlands and Germany
Our German Competition Litigation team regularly hosts webinars on different corporate litigation topics.
Hogan Lovells Events
Paris: Life Sciences and Health Care Horizons 2019
You're Invited: Annual Paris Life Sciences Seminar and Arrival Cocktail for Charlotte Damiano
